Surrey Clinical Research Centre achieves MHRA accreditation
Wednesday 2 June 2010
The Medicines and Healthcare products Regulatory Agency (MHRA) has awarded the Surrey Clinical Research Centre (Surrey CRC) at the University of Surrey standard accreditation for conducting clinical pharmacology Phase I trials.
You should see the Flash movie appearing here. If you are seeing this text instead, it means that you either have JavaScript turned off or you don't have the Flash player installed.
To get Flash Player, visit the Adobe website.
The accreditation scheme was introduced to improve the safety of clinical research volunteers and assesses the capability of the clinical research centre based on facilities, training and experience of staff. The accreditation gives additional reassurance and confidence that the Surrey CRC meets the highest of industry clinical research standards.
Dr Julia Boyle, Director of Surrey CRC, said: "I am very proud to announce the accreditation of the Surrey CRC by the MHRA. Our accreditation success reflects the strong commitment of the University of Surrey - and in particular the Surrey CRC team - to excellence and high-quality research. The Surrey CRC is embedded in an academic environment with international recognition for clinical research. In addition to our academic strength, the accreditation places us firmly alongside the best commercial clinical research organisations in the UK."
Media Enquiries
Peter La, Press Office at the University of Surrey, Tel: +44 (0)1483 689191, or Email mediarelations@surrey.ac.uk